A group of well-known investors, including India SME Fund and Mukul Agarwal, have contributed primary capital to Integris Health, a medical devices company. Everstone Capital supports the company.
According to a press release from Integris Health, the money will be utilized for strategic acquisitions and internal product development projects that will expand the company into several therapeutic areas, including in-vitro diagnostics and laboratory solutions.
To guide its expansion plan, the business named Probir Das CEO in 2024. The company has started preparing for an initial public offering (IPO) and plans to list publicly by the end of 2025.
A medical device company specializing in interventional cardiology, cardiovascular, and vascular surgery therapy, Integris Health was founded in 2008 by Gurmit Singh Chugh. With manufacturing facilities in Germany, the Netherlands, and India, as well as sales in more than 50 markets, this fully integrated company has an end-to-end presence in product development, manufacturing, sales, and distribution.
According to Integris Health, it has developed strategic alliances with top hospitals, engineering schools, international manufacturers of medical technology, and interventional cardiologists over the years. It blends India’s entrepreneurial culture and robust capacity to produce inventive goods at competitive prices with the finest of German engineering, intellectual property, and high standards of quality.
By utilizing its state-of-the-art research and development, strategic alliances, strong distribution networks, and the affordability of Indian production, Integris Health hopes to strengthen the Indian medical technology sector.
